Fundación Gecp

This study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a specific type of advanced lung cancer (ALK-positive NSCLC). About 33 patients will take brigatinib pills and give blood samples over time. The go…

This study tests a combination of two immunotherapy drugs (pembrolizumab and lenvatinib) plus standard chemotherapy in people with extensive-stage small cell lung cancer who have not had prior treatment. The goal is to see if this triple therapy is safe and can delay cancer growt…